Full-Time

Account Associate

Posted on 5/12/2026

Real Chemistry

Real Chemistry

1,001-5,000 employees

Delivers AI-powered, patient-centered healthcare experiences

No salary listed

London, UK + 1 more

More locations: Manchester, UK

Hybrid

Hybrid role; employees within an hour of an office are expected in office 2 days per week.

Category
Sales & Account Management (1)
Required Skills
Salesforce
Requirements
  • Highly organized with a mindfulness of deadlines, the ability to manage multiple tasks based on priorities and a strong attention to detail
  • Independent thinker confident in taking ownership of assets and material development, but a team player who enjoys collaboration
  • Performs tasks with a sense of urgency and has the confidence to communicate with managers when deadlines will not be met or when issues are foreseeable
  • Strong written and oral communication and presentations skills
  • Open minded and eager to learn – the more you put in, the more you get out!
  • High energy, able to effectively operate in fast-paced, growing and evolving environment
  • Able to develop client-ready outputs with attention to detail and quality
  • Experience in reference and proofreading
  • Experience in developing written materials following a detailed brief and managing internal review timings
  • Familiarity with ABPI Code of Practice compliance
  • Familiarity with VVPM system for uploading, tagging and managing items for approval
  • Budgeting awareness and ability to draft budgets and understand financial processes (job codes, purchase orders, Salesforce opportunities)
  • Timesheets and expense claims accuracy and timeliness
  • Ability to build and maintain client relationships through regular contact
  • Organisational skills to manage meetings, minutes, agendas, and logistics
  • Experience in coordinating with external suppliers and KOLs during projects
  • Understanding of client strategy through email management and file organization
  • Ability to tailor communication to different team members' ways of working
  • Experience with briefing processes and project understanding
  • Knowledge of the healthcare communications and pharmaceutical industries
  • Familiarity with ABPI Code of Practice compliance
Responsibilities
  • Be the ‘go-to’ person on your team for completing tasks, identify tasks you can take on and proactively offer your support
  • Take ownership of meetings (internal and external) ensuring: relevant team members are available; they have everything they need to run it (status reports, agendas, etc.); the necessary logistics are in place (room bookings, etc.)
  • Be responsible for driving and managing updates to the status report, ensuring it is regularly updated and internally reviewed prior to client calls and tracking the status of projects
  • Capture accurate minutes from meetings (internal and external), ensuring all internal actions are completed according to the timelines
  • Prepare timelines prior to the commencement of each project (prepared in consultation with relevant team members)
  • Begin to build relationships with your clients, through regular contact (calls/emails)
  • Manage external suppliers on client projects, ensuring they deliver to budget and timelines
  • Organise logistics for small to medium sized external meetings/events, ensuring that costs are aligned with the budget
  • Ensure professional contact with KOLs when undertaking key tasks (e.g. booking travel)
  • Start to build your knowledge of your client’s strategy by staying on top of all emails and saving down files appropriately
  • Tailor your communication to your team members’ ways of working (i.e. Teams vs. emailing, identifying the most appropriate person to respond to questions)
  • Actively participate in the briefing process when you’re being assigned work – arrange the meeting, do any pre-reading, interrogate the brief to confirm your understanding of the project, deadlines and budget

Real Chemistry helps healthcare brands grow by creating AI-powered, customer-centered healthcare experiences. It combines AI-enabled experiences with cross-disciplinary teams to design and deliver programs across patient, provider, and payer touchpoints. The company differentiates itself through large, integrated teams of specialists focused exclusively on healthcare and customer experience under one mission. Its goal is to transform how healthcare is experienced while driving commercial success for healthcare organizations.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

San Francisco, California

Founded

2001

Simplify Jobs

Simplify's Take

What believers are saying

  • International team grew 25% since 2023, exceeding 300 employees outside U.S.
  • Acquisitions of Spring & Bond and Greater Than One add 250 media experts.
  • Double-digit revenue growth in 2024 from AI-driven healthcare marketing.

What critics are saying

  • Spring & Bond integration fails, causing service disruptions in 6-12 months.
  • New leaders Kath Harrison and Brandon Pletsch depart within 12-18 months.
  • RC Resolve loses clients amid drug pricing scrutiny in 3-9 months.

What makes Real Chemistry unique

  • RC Resolve advisory practice deploys ReputAI and HealthGEO for pharma reputation management.
  • Spring & Bond acquisition delivers omnichannel precision media for healthcare clients.
  • Global hubs in Munich, Zurich, Dubai serve multi-market pharma regulatory needs.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Real Chemistry who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Unlimited Paid Time Off

Wellness Program

Mental Health Support

Paid Vacation

Company News

Business Wire
Feb 5th, 2026
Real Chemistry appoints four senior leaders and expands regional hubs to strengthen global healthcare communications presence

Real Chemistry, a global healthcare communications firm, has appointed four senior international leaders and expanded its regional hub presence as part of its global growth strategy. The company is opening new offices in Munich, Zurich and Dubai, with further expansion planned. The appointments include Kath Harrison as Group President, International Growth; Brandon Pletsch as President, Europe; Louise Clark as President, Integrated Communications, Global; and Eleanor Read as President, Integrated Communications, Europe. The leaders bring decades of experience advising global pharmaceutical companies. Since 2023, Real Chemistry's international team has grown 25%, with over 300 employees now working outside the United States. The expansion aims to support healthcare clients navigating complex multi-market environments across Europe, the Middle East, Asia Pacific and Latin America.

PRWeek
Jan 9th, 2026
Real Chemistry launches new advisory practice to elevate pharma's corporate brand reputation

Real Chemistry launches new advisory practice to elevate pharma's corporate brand reputation. Real Chemistry unveiled its new advisory practice, focused on corporate communications and reputation, in advance of the JPMorgan Healthcare Conference. Real Chemistry has launched a new advisory practice that will seek to offer guidance to healthcare and pharma companies from a corporate communications and reputation standpoint. The agency unveiled the advisory, dubbed RC Resolve, in advance of the JPMorgan Healthcare Conference next week. It will focus on the intersection of science, policy, risk management and corporate communications - an area that pharma companies have recognized as increasingly important since the COVID-19 pandemic, according to Jennifer Gottlieb, global president and head of integrated communications at Real Chemistry. "Pharma companies realize they can't just rely on doing communications about each individual product, and that consumers are starting to see them as a company that they need to have a relationship with," Gottlieb explained. RC Resolve launched with three goals, Gottlieb noted, including being an advisory team that's solely focused on healthcare and bringing in a team of executives with experience on the pharma client side. It also aims to incorporate Real Chemistry's data and analytics expertise alongside a proprietary suite of tools including ReputAI and HealthGEO. ReputAI is a reputation measurement and predictive message-testing suite that's designed to manage tough reputation situations and crises, according to Gottlieb, that "measures the back end of reputation and works to improve the trust your organization has with its stakeholders." HealthGEO, which Real Chemistry launched last year, is its generative engine optimization (GEO) tool which helps marketers understand how their companies and brands are showing up in AI platforms and large language models (LLMs). The tool allows marketers to understand where misinformation about their brand may be coming from, and gives them pathways to clarify and fix how it's being perceived. RC Resolve will be manned by several executives who come with communications and reputation experience from the pharma client side, including Bridget Walsh, who will serve as head of policy, public affairs and access. Previously, Walsh served in government affairs and policy leadership roles at Pfizer and Boehringer Ingelheim. Amy Atwood, who previously worked as vice president, U.S. and global corporate communications at Takeda, will serve as RC Resolve's head of transformation and change management. Other appointments include Piper Evans, head of corporate strategy and reputation, who previously worked at McKinsey and the Public Affairs Council. Gottlieb pointed to the external pressures occurring in the healthcare industry in recent years - from biotech funding ebbing and flowing, drug pricing debates, and conversations about healthcare access in the U.S. compared to other countries. As a result, the role of the chief communications or chief corporate affairs officer has become increasingly important in the pharma industry, notes Sherry Pudloski, group president at RC Resolve and corporate affairs at Real Chemistry. "We are mirroring the need of the executive who sits at that table - who is responsible for the external environment and internal environment - and being there to serve his or her needs," Pudloski said. "We want to partner with that person to help guide their executive team on how to make wise multi-stakeholder decisions." That includes battling misinformation in an era where science messaging can be beleaguered by external and political forces. "Clarifying the mis- and disinformation, and making sure that patients are continuing to get the shortest road home to the information they need to get to the best care possible, will continue to be our North Star," Gottlieb said.

Business Wire
Oct 17th, 2025
Real Chemistry Strengthens Media and Omnichannel Leadership with Acquisition of Spring & Bond

Real Chemistry continues to strengthen its media capabilities by acquiring Spring & Bond.

Business Wire
Oct 15th, 2025
Real Chemistry Strengthens Media and Omnichannel Leadership with Acquisition of Spring & Bond

Real Chemistry strengthens media and omnichannel leadership with acquisition of Spring & Bond. Second Acquisition in Three Months Builds Momentum NEW YORK-(BUSINESS WIRE)-Real Chemistry, a leader in AI-driven insights and marketing communications for the healthcare industry, continues to strengthen its media capabilities by acquiring Spring & Bond. A digital media agency known for its omnichannel-first approach and data-driven solutions, Spring & Bond is focused exclusively on healthcare, working with leading healthcare clients. "Real Chemistry is redefining the future of media with a focus on precision over scale. Our expanded media group offers omni-first precision marketing, which is essential for healthcare marketers aiming for personalized audience messaging," said Kevin Johnson, Group President and Managing Partner of Real Chemistry. "Spring & Bond brings a deep knowledge of the healthcare ecosystem, and advanced data and technology capabilities, enabling our clients to connect more meaningfully and effectively with their target audiences." This acquisition follows Real Chemistry's July acquisition of Greater Than One. Together, Real Chemistry's media group now provides end-to-end media activation solutions with over 250 dedicated experts. This includes: * Starting with the right data and healthcare expertise to understand audiences and inform content strategies * Proprietary planning tools that can drive channel strategy and predict future impact * Connecting first-party data across channels to reach precise audiences * True end to end omnichannel strategy, orchestration and execution * Agile, automated measurement, reporting, and optimization Elizabeth Beringer, President and Founder of Spring & Bond, will continue to lead the team, reporting to Johnson. "Joining Real Chemistry enables us to bring even more tools, insights and expertise to our clients," said Elizabeth Beringer. "Finding a partner like Real Chemistry where the focus on clients, innovation and people match ours is the perfect combination." About Real Chemistry Real Chemistry is a commercialization partner to the world's most successful life sciences and healthcare companies. As a leading provider of AI-powered marketing, communications, medical communications and precision media, Herbert Group help the healthcare industry better understand, reach, and engage communities, patients and healthcare professionals. Anchored by its culture of innovation and creativity, its 2,000+ experts enable modern medicines and scientific advances to meet and exceed their potential. Learn more at www.realchemistry.com. About Spring & Bond Spring & Bond is a digital media agency and consultancy specializing in helping pharmaceutical and medical device manufacturers create robust, omnichannel media strategies for both healthcare professionals (HCPs) and consumer audiences. Herbert Group emphasize transparency and client empowerment through comprehensive services, including customer journey planning, media strategy and activation, technology evaluation, in-house capability development, and training. Media: Please email its team at [email protected]. More News From Real Chemistry NEW YORK-( BUSINESS WIRE )-Real Chemistry announces Meenakshi Yadav as Chief AI Products and Solutions Officer, marking a strategic leap in its AI journey... NEW YORK-( BUSINESS WIRE )-Real Chemistry, a leader in AI-driven insights and marketing communications for the healthcare sector, today announced the launch of HealthGEO... NEW YORK-( BUSINESS WIRE )-REAL CHEMISTRY DEEPENS MEDIA AND TECHNOLOGY EDGE WITH ACQUISITION OF GREATER THAN ONE...

Postmedia Network
Oct 15th, 2025
Real Chemistry Strengthens Media and Omnichannel Leadership with Acquisition of Spring & Bond

Real Chemistry strengthens media and omnichannel leadership with acquisition of Spring & Bond. Second Acquisition in Three Months Builds Momentum NEW YORK - Real Chemistry, a leader in AI-driven insights and marketing communications for the healthcare industry, continues to strengthen its media capabilities by acquiring Spring & Bond. A digital media agency known for its omnichannel-first approach and data-driven solutions, Spring & Bond is focused exclusively on healthcare, working with leading healthcare clients. This advertisement has not loaded yet, but your article continues below. "Real Chemistry is redefining the future of media with a focus on precision over scale. Our expanded media group offers omni-first precision marketing, which is essential for healthcare marketers aiming for personalized audience messaging," said Kevin Johnson, Group President and Managing Partner of Real Chemistry. "Spring & Bond brings a deep knowledge of the healthcare ecosystem, and advanced data and technology capabilities, enabling our clients to connect more meaningfully and effectively with their target audiences." This acquisition follows Real Chemistry's July acquisition of Greater Than One. Together, Real Chemistry's media group now provides end-to-end media activation solutions with over 250 dedicated experts. This includes: * Starting with the right data and healthcare expertise to understand audiences and inform content strategies * Proprietary planning tools that can drive channel strategy and predict future impact * Connecting first-party data across channels to reach precise audiences * True end to end omnichannel strategy, orchestration and execution * Agile, automated measurement, reporting, and optimization Elizabeth Beringer, President and Founder of Spring & Bond, will continue to lead the team, reporting to Johnson. "Joining Real Chemistry enables us to bring even more tools, insights and expertise to our clients," said Elizabeth Beringer. "Finding a partner like Real Chemistry where the focus on clients, innovation and people match ours is the perfect combination." About Real Chemistry Real Chemistry is a commercialization partner to the world's most successful life sciences and healthcare companies. As a leading provider of AI-powered marketing, communications, medical communications and precision media, Herbert Group help the healthcare industry better understand, reach, and engage communities, patients and healthcare professionals. Anchored by its culture of innovation and creativity, its 2,000+ experts enable modern medicines and scientific advances to meet and exceed their potential. Learn more at www.realchemistry.com. About Spring & Bond Spring & Bond is a digital media agency and consultancy specializing in helping pharmaceutical and medical device manufacturers create robust, omnichannel media strategies for both healthcare professionals (HCPs) and consumer audiences. Herbert Group emphasize transparency and client empowerment through comprehensive services, including customer journey planning, media strategy and activation, technology evaluation, in-house capability development, and training.